Okamura K, Matsushima M, Takamiya Y, et al. Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity. J Clin Med Res. 2024;16(10):509-517. doi:10.14740/jocmr6058